Delivery devices and methods for leadless cardiac devices

    公开(公告)号:US10773089B2

    公开(公告)日:2020-09-15

    申请号:US15879937

    申请日:2018-01-25

    摘要: Delivery devices, systems, and methods for delivering implantable leadless pacing devices are disclosed. An example delivery device may include an intermediate tubular member and an inner tubular member slidably disposed within a lumen of the intermediate tubular member. A distal holding section may extend distally of a distal end of the intermediate tubular member and define a cavity therein for receiving an implantable leadless pacing device. The device may be configured to enable fluid flushing of the delivery device prior to use, to remove any air from within the device as well as providing the option of fluid flow during use of the delivery device.

    Systems and methods for medical alert management

    公开(公告)号:US10765379B2

    公开(公告)日:2020-09-08

    申请号:US15967772

    申请日:2018-05-01

    摘要: Systems and methods for managing machine-generated medical alerts associated with physiological events detected from one or more patients are described herein. An alert management system may receive medical events detected from a patient and physiological data associated with patient historical medical alerts. The system comprises an alert prioritizer circuit to generate an event priority indicator for the detected medical event, using a comparison between the detected medical event and the physiological data associated with patient historical medical alerts. The system can identify prolific alert patients using the information about the historical medical alerts. The alert prioritizer circuit can adjust a priority of the detected medical event, and an output circuit can present a priority to a user or a process using the event priority indicator and the identification of prolific alert patient.

    Systems and methods to reduce injury in the heart

    公开(公告)号:US10758655B2

    公开(公告)日:2020-09-01

    申请号:US15674911

    申请日:2017-08-11

    摘要: This document discusses, among other things, systems and methods to reduce ischemic or metabolic injury to a patient's heart. A system to reduce ischemic or metabolic injury to a patient's heart may include a pulse generator for generating electrical pulses or shock, a pacing lead with at least one pacing electrode configured to deliver electrical pulses received from the pulse generator to the patient's heart, a controller configured to control timing of electrical pulses to reduce wall stress of the heart, and a reservoir, fluidically coupled to a lumen and a pump, wherein the pump is configured, under control of the controller, to move contents from the reservoir through the lumen to an area of the heart with the reduced wall stress, wherein the contents include autologous respiration-competent mitochondria or other respiratory-promoting agents.

    IMPLANTABLE MEDICAL DEVICE WITH BIOCOMPATIBLE BATTERY SHELL

    公开(公告)号:US20200238095A1

    公开(公告)日:2020-07-30

    申请号:US16750647

    申请日:2020-01-23

    IPC分类号: A61N1/375

    摘要: Embodiments herein relate to implantable medical devices including a power subunit with a first biocompatible electrically conductive shell configured for direct contact with an in vivo environment. In some embodiments a lithium anode can be disposed within the first biocompatible electrically conductive shell in direct electrical communication with a feedthrough pin, wherein the feedthrough pin is electrically isolated from the first biocompatible electrically conductive shell. A cathode can also be disposed within the first biocompatible electrically conductive shell and can be in direct electrical communication with the first biocompatible electrically conductive shell. The first biocompatible electrically conductive shell has a positive electrical potential. The implantable medical device further includes an electronics control subunit with a control circuit disposed within a second biocompatible electrically conductive shell. Other embodiments are included herein.

    Delivery devices and methods for leadless cardiac devices

    公开(公告)号:US10722723B2

    公开(公告)日:2020-07-28

    申请号:US14452617

    申请日:2014-08-06

    IPC分类号: A61M25/00 A61N1/375

    摘要: Delivery devices, systems, and methods for delivering an implantable leadless pacing device having an outer peripheral surface are disclosed. An example delivery device may include a proximal section including a distal end, and a distal holding section extending distally of a distal end of the proximal section. The distal holding section defines a cavity therein for receiving the implantable leadless pacing device, and may be configured to apply a holding force to the implantable leadless pacing device. In some cases, the distal holding section may be configured to apply a compressive force to the outer peripheral surface of the leadless pacing device when the leadless pacing device is disposed in the cavity.

    HIS-BUNDLE PACING FOR RATE REGULARIZATION
    110.
    发明申请

    公开(公告)号:US20200179692A1

    公开(公告)日:2020-06-11

    申请号:US16691171

    申请日:2019-11-21

    IPC分类号: A61N1/362 A61N1/365

    摘要: Systems and methods for pacing cardiac conductive tissue are described. An exemplary system includes an electrostimulation circuit that may generate HBP pulses to stimulate patient physiologic conduction pathway, such as a His bundle or a bundle branch. The system includes an arrhythmia detector to detect an atrial tachyarrhythmia (AT) with intermittent ventricular conduction. A control circuit may sense ventricular activation and, in response to the detected AT indication, determine or update a His-bundle pacing (HBP) configuration. The HBP may be recursively updated on a beat-by-beat basis using the sensed ventricular activation. The electrostimulation circuit may deliver HBP according to the determined or adjusted HBP configuration to regularize ventricular rate during AT.